-
Overview :: Arch Therapeutics, Inc. (ARTH)
Overview
Arch Therapeutics, Inc. (Arch) is a biotechnology company developing an innovative, elegant, and superior approach to the rapid cessation of bleeding (hemostasis*) and control of fluid leakag...
-
Clinical Data :: Arch Therapeutics, Inc. (ARTH)
Christopher Gauland, DPM, East Carolina University – Brody School of Medicine
Presented at SAWC Fall 2022
Conclusion: The novel synthetic self-assembling peptide matrix is made of a proprietary peptid...
-
Product :: Arch Therapeutics, Inc. (ARTH)
The AC5
Surgical Hemostatic Device - more than just a better mousetrap
The hemostasis market is clearly in search of products that work better, faster, and more reliably. The AC5
® Surgical Hemostati...
-
Leadership :: Arch Therapeutics, Inc. (ARTH)
Chairman of the Board of Directors, President and Chief Executive Officer
Terrence W. Norchi, MD, our co-founder, serves as our President and Chief Executive Officer, and he is a director on our Board...
-
AC5 Advanced Wound System :: Arch Therapeutics, Inc. (ARTH)
For more information on AC5
® Advanced Wound System, including Mechanism of Assembly, Key Opinion Leader videos, Preparation Instructions, Case Studies, and more, please visit ac5aws.com.
-
Corporate Mission :: Arch Therapeutics, Inc. (ARTH)
Corporate Mission
The Mission of Arch Therapeutics is to develop products that will improve the lives of patients and enhance the quality of care offered by healthcare personnel. We intend to offer co...